BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 15618480)

  • 1. Ion transport pathology in the mechanism of sickle cell dehydration.
    Lew VL; Bookchin RM
    Physiol Rev; 2005 Jan; 85(1):179-200. PubMed ID: 15618480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic strategies for prevention of sickle cell dehydration.
    Brugnara C
    Blood Cells Mol Dis; 2001; 27(1):71-80. PubMed ID: 11358364
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of 1-chloro-2,4-dinitrobenzene on K+ transport in normal and sickle human red blood cells.
    Muzyamba MC; Gibson JS
    J Physiol; 2003 Mar; 547(Pt 3):903-11. PubMed ID: 12576491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abnormal permeability pathways in human red blood cells.
    Ellory JC; Robinson HC; Browning JA; Stewart GW; Gehl KA; Gibson JS
    Blood Cells Mol Dis; 2007; 39(1):1-6. PubMed ID: 17434766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Established and experimental treatments for sickle cell disease.
    De Franceschi L; Corrocher R
    Haematologica; 2004 Mar; 89(3):348-56. PubMed ID: 15020275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Green tea extract and aged garlic extract inhibit anion transport and sickle cell dehydration in vitro.
    Ohnishi ST; Ohnishi T; Ogunmola GB
    Blood Cells Mol Dis; 2001; 27(1):148-57. PubMed ID: 11358376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple isoforms of the KC1 cotransporter are expressed in sickle and normal erythroid cells.
    Crable SC; Hammond SM; Papes R; Rettig RK; Zhou GP; Gallagher PG; Joiner CH; Anderson KP
    Exp Hematol; 2005 Jun; 33(6):624-31. PubMed ID: 15911086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxygen dependence of K(+)-Cl- cotransport in human red cell ghosts and sickle cells.
    Khan AI; Drew C; Ball SE; Ball V; Ellory JC; Gibson JS
    Bioelectrochemistry; 2004 May; 62(2):141-6. PubMed ID: 15039017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sickle cell dehydration: Pathophysiology and therapeutic applications.
    Brugnara C
    Clin Hemorheol Microcirc; 2018; 68(2-3):187-204. PubMed ID: 29614632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distribution of dehydration rates generated by maximal Gardos-channel activation in normal and sickle red blood cells.
    Lew VL; Tiffert T; Etzion Z; Perdomo D; Daw N; Macdonald L; Bookchin RM
    Blood; 2005 Jan; 105(1):361-7. PubMed ID: 15339840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sickle red cell dehydration: mechanisms and interventions.
    Bookchin RM; Lew VL
    Curr Opin Hematol; 2002 Mar; 9(2):107-10. PubMed ID: 11844992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro inhibitory effects of disodium cromoglycate on ionic transports involved in sickle cell dehydration.
    Bizumukama L; Ferster A; Gulbis B; Kumps A; Cotton F
    Pharmacology; 2009; 83(5):318-22. PubMed ID: 19401631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined genetic disruption of K-Cl cotransporters and Gardos channel KCNN4 rescues erythrocyte dehydration in the SAD mouse model of sickle cell disease.
    Shmukler BE; Rivera A; Bhargava P; Nishimura K; Hsu A; Kim EH; Trudel M; Rust MB; Hubner CA; Brugnara C; Alper SL
    Blood Cells Mol Dis; 2019 Nov; 79():102346. PubMed ID: 31352162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxygen sensitivity of red cell membrane transporters revisited.
    Drew C; Ball V; Robinson H; Clive Ellory J; Gibson JS
    Bioelectrochemistry; 2004 May; 62(2):153-8. PubMed ID: 15039019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of red cell dehydration: a possible new treatment for sickle cell disease.
    Mueller BU; Brugnara C
    Pediatr Pathol Mol Med; 2001; 20(1):15-25. PubMed ID: 12673842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical trials of new therapeutic pharmacology for sickle cell disease].
    Brugnara C; de Franceschi L
    Sante; 2006; 16(4):263-8. PubMed ID: 17446160
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sickle cell disease: from membrane pathophysiology to novel therapies for prevention of erythrocyte dehydration.
    Brugnara C
    J Pediatr Hematol Oncol; 2003 Dec; 25(12):927-33. PubMed ID: 14663274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo studies of sickle red blood cells.
    Kaul DK; Fabry ME
    Microcirculation; 2004 Mar; 11(2):153-65. PubMed ID: 15280089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for a direct reticulocyte origin of dense red cells in sickle cell anemia.
    Bookchin RM; Ortiz OE; Lew VL
    J Clin Invest; 1991 Jan; 87(1):113-24. PubMed ID: 1702096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sickling in vitro of reticulocytes from patients with sickle cell disease at venous oxygen tension.
    Horiuchi K; Onyike AE; Osterhout ML
    Exp Hematol; 1996 Jan; 24(1):68-76. PubMed ID: 8536795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.